Literature DB >> 14741735

Metabolism of cyclic ADP-ribose: Zinc is an endogenous modulator of the cyclase/NAD glycohydrolase ratio of a CD38-like enzyme from human seminal fluid.

Weronika Zielinska1, Hosana Barata, Eduardo N Chini.   

Abstract

CD38, a bifunctional enzyme capable of both synthesis and hydrolysis of the second messenger cyclic ADP-ribose (cADPR). Using the natural substrate of the enzyme, NAD+, the ratio of ADP-ribosyl cyclase/NAD glycohydrolase of CD38 is about 1/100. Here we describe that human seminal fluid contain a soluble CD38 like enzyme with an apparent M.W. of 49 kDa. When purified this enzyme has a cyclase/NAD glycohydrolase ratio of about 1/120. However, the in situ cyclase/NAD glycohydrolase ratio measured in seminal plasma approaches 1/1. We also found that physiological concentrations of zinc present in the seminal fluid, in the range of 0.6 to 4 mM, are responsible for the modulation of the cyclase/NAD glycohydrolase ratio. This new information indicates that the cyclase/NAD glycohydrolase ratio can be modified in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741735     DOI: 10.1016/j.lfs.2003.08.033

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Evidence that the cADPR signalling pathway controls calcium-mediated microneme secretion in Toxoplasma gondii.

Authors:  Eduardo N Chini; Kisaburo Nagamune; Dawn M Wetzel; L David Sibley
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 2.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 3.  NAD and the aging process: Role in life, death and everything in between.

Authors:  Claudia C S Chini; Mariana G Tarragó; Eduardo N Chini
Journal:  Mol Cell Endocrinol       Date:  2016-11-05       Impact factor: 4.102

4.  Seminal CD38 is a pivotal regulator for fetomaternal tolerance.

Authors:  Byung-Ju Kim; Yun-Min Choi; So-Young Rah; Dae-Ryoung Park; Seon-Ah Park; Yun-Jo Chung; Seung-Moon Park; Jong Kwan Park; Kyu Yun Jang; Uh-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-15       Impact factor: 11.205

Review 5.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Lipopolysaccharide induces CD38 expression and solubilization in J774 macrophage cells.

Authors:  Cha-Uk Lee; Eun-Kyung Song; Chae-Hwa Yoo; Yong-Keun Kwak; Myung-Kwan Han
Journal:  Mol Cells       Date:  2012-11-23       Impact factor: 5.034

Review 7.  The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

Authors:  Eduardo N Chini; Claudia C S Chini; Jair Machado Espindola Netto; Guilherme C de Oliveira; Wim van Schooten
Journal:  Trends Pharmacol Sci       Date:  2018-02-23       Impact factor: 14.819

8.  Sperm express a Ca2+-regulated NAADP synthase.

Authors:  Sridhar R Vasudevan; Antony Galione; Grant C Churchill
Journal:  Biochem J       Date:  2008-04-01       Impact factor: 3.857

Review 9.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

10.  The new insight into extracellular NAD+ degradation-the contribution of CD38 and CD73 in calcific aortic valve disease.

Authors:  Patrycja Jablonska; Barbara Kutryb-Zajac; Paulina Mierzejewska; Agnieszka Jasztal; Barbara Bocian; Romuald Lango; Jan Rogowski; Stefan Chlopicki; Ryszard T Smolenski; Ewa M Slominska
Journal:  J Cell Mol Med       Date:  2021-06-18       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.